Innovating in care delivery
At MSK, we are committed to empowering people with cancer to live the lives they choose, during treatment and beyond. Donor support enables us to deliver the best care to every patient — no matter who they are — throughout every step of their cancer journey.
Building a foundation of excellence
For many years, MSK has ranked among the best hospitals in the world for cancer. Thanks to your support, we have been able to:
- Expand our services through our Regional Care Network.
- Become home to one of the largest clinical trial programs in the country.
- Improve health equity by addressing disparate outcomes among our patients from medically underserved populations.
To set the pace for a bright future
MSK Campaign donors are already making a difference. In 2026, we:
- Broke ground on The Kenneth C. Griffin Pavilion at Memorial Sloan Kettering Cancer Center, which will enable MSK to reach more patients with the most advanced therapies while creating the infrastructure to deliver increasingly sophisticated cancer care for decades to come.
- Built on years of research at the David M. Rubenstein Center for Pancreatic Cancer Research to advance breakthrough treatments for this challenging disease, including an investigational personalized mRNA vaccine and a new FDA approved targeted treatment, daraxonrasib (RasonqueTM).
Diagnosed with stage 4 cancer during pregnancy, Kassandra turned to MSK for care.
Read Kassandra's story
Funding innovations in clinical strategy
A historic partnership
In 2023, Kenneth C. Griffin and David Geffen pledged a $400 million gift to MSK. It will serve as the cornerstone of our foundation for the future with a focus on elevating care for our patients and people with cancer everywhere.
Read moreHelping young people with cancer
Scott Stuart, Chair of MSK’s Board of Trustees, and his family launched the Lisa and Scott Stuart Center for Adolescent and Young Adult Cancers to meet the specific and often unmet needs of people with cancer between ages 15 and 39.
Learn moreA new leader in supportive care
MSK Trustee Jonathan Grayer endowed the Fern Grayer Chair in Oncology and Patient Experience, held by Corita Grudzen, MD, MSHS, who is leading efforts to make evidence-based improvements in care delivery.
Read about Dr. GrudzenShaping cancer care worldwide
Seven in every 10 cancer deaths occur in low- and middle-income countries. With donor support, the Global Cancer Research and Training Program at MSK works to improve outcomes for people with cancer living in these areas.
Discover the initiativeA gift in memory of “Nonna”
To honor his beloved grandmother, donor Mike Repole; his wife, Maria; and the Nonna’s Garden Foundation made a generous gift toward research and patient care at MSK, including at the MSK Commack Nonna’s Garden Foundation Center.
Read the story
Help innovate cancer care and clinical strategy
The MSK Campaign: Leading Science. Changing Lives.
The MSK community is raising $6 billion by 2030 to accelerate advances across six key strategic initiatives. Learn more and join us in our mission of ending cancer for life.
Learn more about The MSK Campaign